Gastric Cancer (Oncology) – Drugs In Development, 2021

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Drugs In Development, 2021, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, stomach pain, vomiting, weight loss that is unintentional, feeling bloated after eating, heartburn and indigestion. Risk factors include smoking, pernicious anemia, stomach polyps, infection with helicobacter pylori and family history of stomach cancer. Treatment includes surgery, chemotherapy and radiation therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Gastric Cancer – Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Gastric Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 1, 23, 180, 223, 5, 26, 202, 42 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical and Discovery stages comprises 12, 10, 1, 1, 9 and 3 molecules, respectively.

Gastric Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Gastric Cancer (Oncology).

– The pipeline guide reviews pipeline therapeutics for Gastric Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Gastric Cancer (Oncology) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Gastric Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Gastric Cancer (Oncology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Gastric Cancer (Oncology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Gastric Cancer (Oncology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies mentioned

3SBio Inc

AbbVie Inc

Abclon Inc

Abion Inc

ABL Bio Inc

Abpro Corp

AbTis Co Ltd

Accurus Biosciences Inc

Acrotech Biopharma LLC

AD Pharmaceuticals Co Ltd

Adaptimmune Therapeutics Plc

ADC Therapeutics SA

Advenchen Laboratories LLC

Affimed GmbH

AffyImmune Therapeutics Inc

Agenus Inc

AIMM Therapeutics BV

Akeso Inc

Alkermes Plc

Alligator Bioscience AB

Alphamab Oncology

Alteogen Inc

AltruBio Inc

ALX Oncology Holdings Inc

Ambrx Biopharma Inc

amcure GmbH

Amgen Inc

Andes Biotechnologies

Anew Oncology Inc

Anhui Anke Biotechnology (Group) Co Ltd

Antikor Biopharma Ltd

Apollomics Inc

Apotex Inc

Aprea Therapeutics Inc

Arbele Ltd

Arcus Biosciences Inc

Argonaut Therapeutics Ltd

Arog Pharmaceuticals Inc

Arromax Pharmatech Co Ltd

Aryogen Pharmed

Asana BioSciences LLC

Ascelia Pharma AB

Ascenta Therapeutics Inc

Ascentage Pharma Group International

AskAt Inc

Aslan Pharmaceuticals Ltd

Astellas Pharma Inc

AstraZeneca Plc

Atara Biotherapeutics Inc

Aurigene Discovery Technologies Ltd

Aurora BioPharma Inc

Avvinity Therapeutics Ltd

Basilea Pharmaceutica Ltd

Bavarian Nordic A/S

Bayer AG

BeiGene Ltd

Beijing BGI-GBI Biotech Co Ltd

Beijing Biostar Technologies Ltd

Beijing Combio Pharmaceuticals Ltd

Beijing Hanmi Pharmaceutical Co Ltd

Beijing Immunochina Pharmaceuticals Co Ltd

Beijing Konruns Pharmaceutical Co Ltd

Beijing Mabworks Biotech Co Ltd

Beijing Scitech-MQ Pharmaceuticals Ltd

Beijing Shenzhou Cell Biotechnology Group Co Ltd

Beijing Syngentech Co Ltd

Bellicum Pharmaceuticals Inc

Benhealth Biopharmaceutical (Shenzhen) Co Ltd

Betta Pharmaceuticals Co Ltd

Bicara Therapeutics Inc

Bicycle Therapeutics Plc

Bika Biotechnology Guanzhou Co Ltd

Bio-Synectics Inc

Bio-Thera Solutions Ltd

BioAtla Inc

BioEclipse Therapeutics Inc

BioIntegrator Ltd

BioLineRx Ltd

Biomunex Pharmaceuticals

BioNTech SE

Biosion Inc

BioSplice Therapeutics Inc

BioSyngen Pte Ltd

Biotecnol Ltd

BJ Bioscience Inc

Black Diamond Therapeutics Inc

Bliss Biopharmaceutical (Hangzhou) Co Ltd

Blueprint Medicines Corp

Boehringer Ingelheim International GmbH

Bold Therapeutics Inc

Bolt Biotherapeutics Inc

BrickBio Inc

BridgeBio Pharma Inc

Bristol-Myers Squibb Co

Byondis BV

Calico Life Sciences LLC

CalyGene Biotechnology Inc

CanBas Co Ltd

Cancer Prevention Pharmaceuticals Inc

Cannabics Pharmaceuticals Inc

Carisma Therapeutics Inc

CARsgen Therapeutics Ltd

CAS-Lamvac Biotech Co Ltd

Catalent Inc

Celldex Therapeutics Inc

Cellestia Biotech AG

Cellid Co Ltd

Cellivery Therapeutics Inc

Cello Therapeutics Inc

Celon Pharma SA

Celularity Inc

Cend Therapeutics Inc

Centrymed Pharmaceutical Inc

Checkmate Pharmaceuticals Inc

Chengdu Jinrui Foundation Biotechnology Co Ltd

Chengdu Kanghong Pharmaceuticals Group Co Ltd

Chia Tai Tianqing Pharmaceutical Group Co Ltd

China Immunotech (Beijing) Biotechnology Co Ltd

Chong Kun Dang Pharmaceutical Corp

Chugai Pharmaceutical Co Ltd

Cloaked Therapeutics LLC

CMG Pharmaceutical Co Ltd

Coherent Biopharma

Conagen Inc

Constellation Pharmaceuticals Inc

Convalife

CSPC Pharmaceutical Group Ltd

CStone Pharmaceuticals Co Ltd

Cumberland Pharmaceuticals Inc

Curegenix Inc

CureLab Oncology Inc

CureMeta LLC

Cynvec LLC

Cytocom Inc

Cytodyn Inc

CytoImmune Therapeutics Inc

CytoMed Therapeutics Pte Ltd

CytomX Therapeutics Inc

Daiichi Sankyo Co Ltd

Defence Therapeutics Inc

Delta-Fly Pharma Inc

DiNonA Inc

DM Bio Ltd

DNAtrix Inc

Dongguan Daxin Biotechnology Co Ltd

Dragonfly Therapeutics Inc

Dyadic International Inc

Eddingpharm Inc

Eden Biologics Inc

eFFECTOR Therapeutics Inc

EirGenix Inc

Eisai Co Ltd

Eli Lilly and Co

Ella Therapeutics Ltd

Elucida Oncology Inc

EOS Biosciences Inc

EpimAb Biotherapeutics Inc

EpiThany Inc

Epsilogen Ltd

ERYTECH Pharma SA

Esperance Pharmaceuticals Inc

eTheRNA Immunotherapies NV

Eutilex Co Ltd

Excelmab Inc

Exelixis Inc

EXUMA Biotech Inc

F-star Therapeutics Inc

F. Hoffmann-La Roche Ltd

Faron Pharmaceuticals Oy

Fate Therapeutics Inc

Frost Biologic Inc

FutureGen Biopharm Technology Co Ltd

G+FLAS Life Sciences Inc

GAiA BioMedicine Inc

Galecto Inc

GC Pharma

GEMoaB Monoclonals GmbH

Geneius Biotechnology Inc

Genentech USA Inc

GeneQuantum Healthcare Suzhou Co Ltd

GeneScience Pharmaceuticals Co Ltd

Genexine Inc

Genmab AS

GenoImmune Therapeutics Biotechnology Co Ltd

Genome & Co

Gilead Sciences Inc

GlaxoSmithKline Plc

GLG Pharma SA

GlycoNex Inc

Glycotope GmbH

Gossamer Bio Inc

Green Cross LabCell Corp

Grid Therapeutics LLC

Guangdong Yinzhu Pharmaceutical Technology Co Ltd

Guangdong Zhongsheng Pharmaceutical Co Ltd

Guangzhou BeBetter Medicine Technology Co Ltd

Haikou Qili Pharmaceutical Co Ltd

HaimBio Ltd

Hainan Kaibo Biotechnology Co Ltd

Hangzhou Bensheng Pharmaceutical Co Ltd

Hangzhou DAC Biotech Co Ltd

Hanmi Pharmaceuticals Co Ltd

Harbin Gloria Pharmaceuticals Co Ltd

Harbour BioMed (Guangzhou) Co Ltd

Helixmith Co Ltd

Hengenix Biotech Inc

HengRui YuanZheng Bio-Technology Co Ltd

Hibercell Inc

Highlight Therapeutics SL

HitGen Inc

Hope Biosciences Inc

Horizon Therapeutics Plc

Huabo Biopharm (Shanghai) Co Ltd

Huadao Shanghai Biomedical Co Ltd

Hummingbird Bioscience Pte Ltd

Hutchison MediPharma Ltd

I-Mab

Ichnos Sciences Inc

Ideaya Biosciences Inc

Idience Co Ltd

IGM Biosciences Inc

ImCheck Therapeutics SAS

ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd

Immunicum AB

Immunisbio Co Ltd

ImmunityBio Inc

Immunocore Holdings Plc

Immunomet Therapeutics Inc

Immunomic Therapeutics Inc

Immunotech Biopharm Ltd

Imugene Ltd

Incyte Corp

Inhibrx Inc

Inner Mongolia Qite Biotechnology (Group) Co Ltd

Innovative Cellular Therapeutics Co Ltd

Innovent Biologics Inc

Inovio Pharmaceuticals Inc

Intocell Inc

Intra-Immusg Pvt Ltd

InxMed Shanghai Co Ltd

Ipsen SA

Istari Oncology Inc

Ithax Pharmaceuticals Inc

JenKem Technology Co Ltd

Jiangsu Aosaikang Pharmaceutical Co Ltd

Jiangsu Atom Bioscience and Pharmaceutical Co Ltd

Jiangsu Hengrui Medicine Co Ltd

Jiangsu Kanion Pharmaceutical Co Ltd

Jina Pharmaceuticals Inc

Jiuzhitang Co Ltd

Johnson & Johnson

Joint Biosciences Ltd

Jounce Therapeutics Inc

JW Pharmaceutical Corp

Karyo Biologics LLC

Karyopharm Therapeutics Inc

KeyMed Biosciences Inc

Keythera Pharmaceuticals Co Ltd

Kintor Pharmaceutical Ltd

KLUS Pharma Inc

Komipharm International Co Ltd

Kringle Pharma Inc

Kupffer Biotherapeutics Inc

Kymab Ltd

Kyowa Kirin Co Ltd

LaNova Medicines Ltd

LATITUDE Pharmaceuticals Inc

Lead Discovery Center GmbH

Leap Therapeutics Inc

Legend Biotech Corp

LegoChem Biosciences Inc

Lepu Biopharma Co Ltd

Leukocare AG

Liminatus Pharma LLC

LintonPharm Co Ltd

LipoMedix Pharmaceutical Inc

Livzon Pharmaceutical Group Co Ltd

Luye Pharma Group Ltd

Lycera Corp

Lytix Biopharma AS

Mabpharm Ltd

MacroGenics Inc

MaxiVAX SA

MBQ Pharma Inc

Mecox Cure Med Co Ltd

MedAbome Inc

Meditope Biosciences Inc

MedPacto Inc

Merck & Co Inc

Merck KGaA

Mereo Biopharma Group Plc

Merus NV

Metagone Biotech Inc

Metis Precision Medicine

Midissia Therapeutics Inc

Millennium Pharmaceuticals Inc

Mirati Therapeutics Inc

Mitsubishi Tanabe Pharma Corp

Moderna Inc

Molecular Partners AG

Molecular Templates Inc

Moleculin Biotech Inc

Morphogenesis Inc

Multitude therapeutics Inc

Mustang Bio Inc

Mycenax Biotech Inc

Myeloid Therapeutics Inc

Nanjing Bioheng Biotech Co Ltd

Nanjing CART Medical Technology Co Ltd

Nanjing Iaso Biotherapeutics Co Ltd

Nanjing Tianyi Bioscience Co Ltd

Nanjing Transthera Biosciences Co Ltd

NanoCarrier Co Ltd

NanoMab Technology Ltd

NeuClone Pty Ltd

NewBio Therapeutics Inc

NextCure Inc

NGM Biopharmaceuticals Inc

Nouscom AG

NovaRock Biotherapeutics Inc

Novartis AG

Novonco Pharmaceuticals Inc

OBI Pharma Inc

Ocellaris Pharma Inc

Ona Therapeutics SL

OncoC4 Inc

Oncolys BioPharma Inc

Onconic Therapeutics Co Ltd

OncoSynergy Inc

OncoTherapy Science Inc

OncXerna Therapeutics Inc

Ono Pharmaceutical Co Ltd

Onxeo SA

Opsona Therapeutics Ltd

Orano Med LLC

Origincell Technology Group Co Ltd

Oxford BioTherapeutics Ltd

Parasol Biotech Co Ltd

Patrys Ltd

PersonGen Biomedicine Suzhou Co Ltd

Pfizer Inc

Phanes Therapeutics Inc

Pharma Mar SA

Pharmapraxis

Philogen SpA

Phosplatin Therapeutics LLC

Pieris Pharmaceuticals Inc

Pionyr Immunotherapeutics Inc

PlantForm Corp

Plus Therapeutics Inc

PNB Vesper Life Science Pvt Ltd

Precirix NV

Prescient Therapeutics Ltd

Prestige BioPharma Ltd

Protheragen Inc

Puma Biotechnology Inc

Qilu Pharmaceutical Co Ltd

Qilu Puget Sound Biotherapeutics Corp

Quadriga BioSciences Inc

QureBio Ltd

Rakuten Medical Inc

RAPT Therapeutics Inc

RaQualia Pharma Inc

Redx Pharma Plc

Relay Therapeutics Inc

RemeGen Co Ltd

Rhizen Pharmaceuticals SA

Rongchang Pharmaceuticals Ltd

RUS Pharmtech

S.Biomedics Co Ltd

Samyang Biopharmaceuticals Corp

Sanofi

Scancell Holdings Plc

Seagen Inc

SELLAS Life Sciences Group Inc

Seven and Eight Biopharmaceuticals Corp

Shandong Boan Biotechnology Co Ltd

Shandong Golden Brick Biotechnology Co Ltd

Shanghai Biomed-Union Biotechnology Co Ltd

Shanghai Bioray Laboratory Inc

Shanghai GeneChem Co Ltd

Shanghai Haihe Biopharma Co Ltd

Shanghai Henlius Biotech Inc

Shanghai icell Biotechnology Co Ltd

Shanghai Junshi Bioscience Co Ltd

Shanghai Keqi Pharmaceutical Technology Co Ltd

Shanghai Longyao Biotechnology Co Ltd

Shanghai Miracogen Inc

Shanghai PerHum Therapeutics Co Ltd

Shanghai Pharmaceutical Group Co Ltd

Shanghai Sunstem Biotechnology Co Ltd

Shanghai Xunhe Pharmaceutical Technology Co Ltd

Shanghai Yihao Biotechnology Co Ltd

Shaperon Inc

Shenogen Pharma Group Ltd

Shenyang Dongxing Pharmaceutical Co Ltd

Shenzhen BinDeBio Ltd

Shenzhen Chipscreen Biosciences Co Ltd

Shenzhen Fapon Biopharma Inc

Shenzhen Hornetcorn Bio-technology Company Ltd

Shenzhen NeoCura Biotechnology Corp

Shijiazhuang No. 4 Pharmaceutical Co Ltd

Shijiazhuang Sagacity New Drug Development Co Ltd

Sichuan Kelun Pharmaceutical Co Ltd

Silicon Therapeutics LLC

Sillajen Biotherapeutics

Silverback Therapeutics Inc

Simcha Therapeutics Inc

Sino Biopharmaceutical Ltd

SN BioScience

Sorrento Therapeutics Inc

Sotio AS

Sparx Therapeutics Inc

ST Pharm Co Ltd

Stcube Inc

Stemirna Therapeutics Ltd

Sumitomo Dainippon Pharma Co Ltd

Suntec Medical (Taiwan) Inc

Surface Oncology Inc

Suzhou Maximum Bio-tech Co Ltd

Suzhou Sinovent Pharmaceuticals Co Ltd

Suzhou Zanrong Pharmaceutical Technology Co Ltd

Suzhou Zelgen Biopharmaceutical Co Ltd

Symphogen A/S

SynCore Biotechnology Co Ltd

SynOx Therapeutics Ltd

Systimmune Inc

T-Cure Bioscience Inc

Tachyon Therapeutics Inc

TAE Life Sciences LLC

Taiho Oncology Inc

Taiho Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd

Takis Srl

Tarus Therapeutics Inc

Tarveda Therapeutics Inc

Tasly Pharmaceutical Group Co Ltd

Teclison Ltd

TempestTx, Inc.

Tessa Therapeutics Ltd

Themis Bioscience GmbH

Tonix Pharmaceuticals Holding Corp

Toray Industries Inc

TOT Biopharm Co Ltd

Transcenta Holding Ltd

Transcode Therapeutics Inc

Treos Bio Ltd

Trio Medicines Ltd

Turning Point Therapeutics Inc

Turnstone Biologics Inc

Tvardi Therapeutics Inc

Tyg Oncology Ltd

Ube Industries Ltd

UCB SA

United BioPharma Inc

United Immunity Co Ltd

VacV Biotherapeutics Ltd

Vaxon Biotech

Vedanta Biosciences Inc

Venus Remedies Ltd

Viracta Therapeutics Inc

Viralytics Pty Ltd

VM Discovery Inc

Wellington Zhaotai Therapies Ltd

WellMarker Bio Co Ltd

Wuhan YZY Biopharma Co Ltd

Xcovery Holding Co LLC

Xencor Inc

Xiangxue Life Sciences

XuanZhu Biological Technology Co Ltd

Zai Lab Ltd

Zhejiang Doer Biologics Corp

Zhejiang Hisun Pharmaceutical Co Ltd

Zhejiang Jianfeng Group Company Ltd

Zymeworks Inc

Table of Contents

Table of Contents

Introduction

Gastric Cancer - Overview

Gastric Cancer - Therapeutics Development

Gastric Cancer - Therapeutics Assessment

Gastric Cancer - Companies Involved in Therapeutics Development

Gastric Cancer - Drug Profiles

Gastric Cancer - Dormant Projects

Gastric Cancer - Discontinued Products

Gastric Cancer - Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Gastric Cancer, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Products under Development by Companies, 2021

Products under Development by Universities/Institutes, 2021

Number of Products by Stage and Target, 2021

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Gastric Cancer – Pipeline by 3SBio Inc, 2021

Gastric Cancer – Pipeline by AbbVie Inc, 2021

Gastric Cancer – Pipeline by Abclon Inc, 2021

Gastric Cancer – Pipeline by Abion Inc, 2021

Gastric Cancer – Pipeline by ABL Bio Inc, 2021

Gastric Cancer – Pipeline by Abpro Corp, 2021

Gastric Cancer – Pipeline by AbTis Co Ltd, 2021

Gastric Cancer – Pipeline by Accurus Biosciences Inc, 2021

Gastric Cancer – Pipeline by Acrotech Biopharma LLC, 2021

Gastric Cancer – Pipeline by AD Pharmaceuticals Co Ltd, 2021

Gastric Cancer – Pipeline by Adaptimmune Therapeutics Plc, 2021

Gastric Cancer – Pipeline by ADC Therapeutics SA, 2021

Gastric Cancer – Pipeline by Advenchen Laboratories LLC, 2021

Gastric Cancer – Pipeline by Affimed GmbH, 2021

Gastric Cancer – Pipeline by AffyImmune Therapeutics Inc, 2021

Gastric Cancer – Pipeline by Agenus Inc, 2021

Gastric Cancer – Pipeline by AIMM Therapeutics BV, 2021

Gastric Cancer – Pipeline by Akeso Inc, 2021

Gastric Cancer – Pipeline by Alkermes Plc, 2021

Gastric Cancer – Pipeline by Alligator Bioscience AB, 2021

Gastric Cancer – Pipeline by Alphamab Oncology, 2021

Gastric Cancer – Pipeline by Alteogen Inc, 2021

Gastric Cancer – Pipeline by AltruBio Inc, 2021

Gastric Cancer – Pipeline by ALX Oncology Holdings Inc, 2021

Gastric Cancer – Pipeline by Ambrx Biopharma Inc, 2021

Gastric Cancer – Pipeline by amcure GmbH, 2021

Gastric Cancer – Pipeline by Amgen Inc, 2021

Gastric Cancer – Pipeline by Andes Biotechnologies, 2021

Gastric Cancer – Pipeline by Anew Oncology Inc, 2021

Gastric Cancer – Pipeline by Anhui Anke Biotechnology (Group) Co Ltd, 2021

Gastric Cancer – Pipeline by Antikor Biopharma Ltd, 2021

Gastric Cancer – Pipeline by Apollomics Inc, 2021

Gastric Cancer – Pipeline by Apotex Inc, 2021

Gastric Cancer – Pipeline by Aprea Therapeutics Inc, 2021

Gastric Cancer – Pipeline by Arbele Ltd, 2021

Gastric Cancer – Pipeline by Arcus Biosciences Inc, 2021

Gastric Cancer – Pipeline by Argonaut Therapeutics Ltd, 2021

Gastric Cancer – Pipeline by Arog Pharmaceuticals Inc, 2021

Gastric Cancer – Pipeline by Arromax Pharmatech Co Ltd, 2021

Gastric Cancer – Pipeline by Aryogen Pharmed, 2021

Gastric Cancer – Pipeline by Immunicum AB, 2021

Gastric Cancer – Pipeline by Immunisbio Co Ltd, 2021

Gastric Cancer – Pipeline by ImmunityBio Inc, 2021

Gastric Cancer – Pipeline by Immunocore Holdings Plc, 2021

Gastric Cancer – Pipeline by Immunomet Therapeutics Inc, 2021

Gastric Cancer – Pipeline by Immunomic Therapeutics Inc, 2021

Gastric Cancer – Pipeline by Immunotech Biopharm Ltd, 2021

Gastric Cancer – Pipeline by Imugene Ltd, 2021

Gastric Cancer – Pipeline by Incyte Corp, 2021

Gastric Cancer – Pipeline by Inhibrx Inc, 2021

Gastric Cancer – Pipeline by Inner Mongolia Qite Biotechnology (Group) Co Ltd, 2021

Gastric Cancer – Pipeline by Innovative Cellular Therapeutics Co Ltd, 2021

Gastric Cancer – Pipeline by Innovent Biologics Inc, 2021

Gastric Cancer – Pipeline by Inovio Pharmaceuticals Inc, 2021

Gastric Cancer – Pipeline by Intocell Inc, 2021

Gastric Cancer – Pipeline by Intra-Immusg Pvt Ltd, 2021

Gastric Cancer – Pipeline by InxMed Shanghai Co Ltd, 2021

Gastric Cancer – Pipeline by Ipsen SA, 2021

Gastric Cancer – Pipeline by Istari Oncology Inc, 2021

Gastric Cancer – Pipeline by Ithax Pharmaceuticals Inc, 2021

Gastric Cancer – Pipeline by JenKem Technology Co Ltd, 2021

Gastric Cancer – Pipeline by Jiangsu Aosaikang Pharmaceutical Co Ltd, 2021

Gastric Cancer – Pipeline by Jiangsu Atom Bioscience and Pharmaceutical Co Ltd, 2021

Gastric Cancer – Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021

Gastric Cancer – Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, 2021

Gastric Cancer – Pipeline by Jina Pharmaceuticals Inc, 2021

Gastric Cancer – Pipeline by Jiuzhitang Co Ltd, 2021

Gastric Cancer – Pipeline by Johnson & Johnson, 2021

Gastric Cancer – Pipeline by Joint Biosciences Ltd, 2021

Gastric Cancer – Pipeline by Jounce Therapeutics Inc, 2021

Gastric Cancer – Pipeline by JW Pharmaceutical Corp, 2021

Gastric Cancer – Pipeline by Karyo Biologics LLC, 2021

Gastric Cancer – Pipeline by Karyopharm Therapeutics Inc, 2021

Gastric Cancer – Pipeline by KeyMed Biosciences Inc, 2021

Gastric Cancer – Pipeline by Keythera Pharmaceuticals Co Ltd, 2021

Gastric Cancer – Pipeline by Kintor Pharmaceutical Ltd, 2021

Gastric Cancer – Pipeline by KLUS Pharma Inc, 2021

Gastric Cancer – Pipeline by Komipharm International Co Ltd, 2021

Gastric Cancer – Pipeline by Kringle Pharma Inc, 2021

Gastric Cancer – Pipeline by Kupffer Biotherapeutics Inc, 2021

Gastric Cancer – Pipeline by Kymab Ltd, 2021

Gastric Cancer – Pipeline by Kyowa Kirin Co Ltd, 2021

Gastric Cancer – Pipeline by LaNova Medicines Ltd, 2021

Gastric Cancer – Pipeline by LATITUDE Pharmaceuticals Inc, 2021

Gastric Cancer – Pipeline by Lead Discovery Center GmbH, 2021

Gastric Cancer – Pipeline by Leap Therapeutics Inc, 2021

Gastric Cancer – Pipeline by Turnstone Biologics Inc, 2021

Gastric Cancer – Pipeline by Tvardi Therapeutics Inc, 2021

List of Figures

List of Figures

Number of Products under Development for Gastric Cancer, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Number of Products by Top 10 Targets, 2021

Number of Products by Stage and Top 10 Targets, 2021

Number of Products by Top 10 Mechanism of Actions, 2021

Number of Products by Stage and Top 10 Mechanism of Actions, 2021

Number of Products by Top 10 Routes of Administration, 2021

Number of Products by Stage and Top 10 Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports